Targeted Deprescribing in Patients on Hemodialysis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Targeted Deprescribing in Patients on Hemodialysis — Stella

Home/End Stage Renal Disease on Dialysis (Diagnosis)/

View on ClinicalTrials.gov

Recruiting

Back to End Stage Renal Disease on Dialysis (Diagnosis) trials

Trial locations(4 sites)

Canada

Providence Health Care, Vancouver, British Colombia

Manitoba Renal Program, Winnipeg, Manitoba

Nova Scotia Health Authority, Halifax, Nova Scotia

University Health Network, Toronto, Ontario

Key details

Sponsor

University Health Network, Toronto

Enrollment target

~480 participants

Started

October 2022

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.